Combimatrix Corp (CBMX): Robert Hoffman , director of Combimatrix Corp purchased 5,000 shares on May 10, 2016. The Insider buying transaction was reported by the company on May 10, 2016 to the Securities and Exchange Commission. The shares were purchased at $3.19 per share for a total value of $15,962.50 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on May 10, 2016, Scott Gottlieb (director) purchased 4,000 shares at $3.04 per share price.On Feb 24, 2016, Scott R Burell (CFO, Secretary & Treasurer) sold 454 shares at $4.50 per share price.Also, On Jan 14, 2016, Mark D Mcdonough (President and CEO) sold 21,552 shares at $0.55 per share price.
Shares of CombiMatrix Corp (CBMX) ended Friday, May 6, 2016 session in red amid volatile trading. The shares closed down -0.1 points or -3.30% at $2.93 with 18,218 shares getting traded. Post opening the session at $3.03, the shares hit an intraday low of $2.76 and an intraday high of $3.03 and the price vacillated in this range throughout the day. The company has a market cap of $2.5 M and the number of outstanding shares has been calculated to be 8,51,680 shares. The 52-week high of CombiMatrix Corp is $28.199859 and the 52-week low is $2.69.
CombiMatrix Corporation is a molecular diagnostics company. The Company operates in the field of genetic analysis and molecular diagnostics through its wholly owned subsidiary CombiMatrix Molecular Diagnostics Inc. located in Irvine California. The Company operates as a diagnostics reference laboratory providing DNA-based clinical diagnostic testing services to physicians hospitals clinics and other laboratories in the areas of pre-and postnatal development disorders and hematology/oncology genomics. The Company’s oligo arrays allow the Company to perform aCGH on a much more refined scale than is possible with BAC technology.